BIIG THERAPEUTICS BREAKTHROUGH INNOVATION, INSIGHT & GROWTH
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Sept 2019)
What this means for you
This application is over — abandoned 02 Sept 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87764691
- Mark type
- Design + words
- Filed
- 22 Jan 2018
- Published for opposition
- 04 Dec 2018
- Abandoned
- 02 Sept 2019
- Attorney of record
- Scott W. Pink
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical drugs and medicines for the treatment of acute and chronic infectious diseases
- Class 040 — Treatment of materials: Manufacture of pharmaceuticals and biopharmaceutical drugs and medicines to order and/or specification of others
- Class 042 — Scientific and technological services: Research and development of pharmaceutical and biopharmaceutical drugs and medicines; research and development in the pharmaceutical, life sciences and biotechnology fields
Owner
- BRII BIOSCIENCES LIMITED, SHANGHAI, KY
- BRII BIOSCIENCES LIMITED, SHANGHAI, KY
- BiiG THERAPEUTICS LIMITED, SHANGHAI, KY
Prosecution history
- 03 Sept 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Sept 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 29 Jan 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jan 2019 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 04 Dec 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Dec 2018 — PUBLISHED FOR OPPOSITION
- 14 Nov 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Oct 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 27 Oct 2018 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 27 Oct 2018 — ASSIGNED TO LIE
- 16 Oct 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Oct 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Oct 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Oct 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Oct 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED